BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ChemoCentryx\, Inc.\; Proposal To Withdraw Approval of New Dr
 u
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-08455-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260629
DTEND;VALUE=DATE:20260630
SUMMARY:FDA comments close: ChemoCentryx\, Inc.\; Proposal To Withdraw App
 roval of New Drug Application for TAVNEOS (Avacopan) Capsule\, 10 Milligr
 ams\; Opportunity for a Hearing
DESCRIPTION:Notice. Federal Register 2026-08455. Docket FDA-2026-N-1321. D
 etails: https://docket-clock.pages.dev/doc/2026-08455/ Official: https://
 www.federalregister.gov/documents/2026/04/30/2026-08455/chemocentryx-inc-
 proposal-to-withdraw-approval-of-new-drug-application-for-tavneos-avacopa
 n-capsule
URL:https://www.federalregister.gov/documents/2026/04/30/2026-08455/chemoc
 entryx-inc-proposal-to-withdraw-approval-of-new-drug-application-for-tavn
 eos-avacopan-capsule
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR